Study on Safety, Absorption and Metabolism of SYHA1402 Tablets in Healthy People

Clinical trial NCT03988413 · COMPLETED

Trial details

NCT number: NCT03988413
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Neuropathy Peripheral

Start date: 2019-08-05
Primary completion: 2020-01-14
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.